| P50 | author | Gene P. Siegal | Q93491237 |
| P2093 | author name string | Anandi Sawant | |
| | Diptiman Chanda | |
| | Selvarangan Ponnazhagan | |
| | Sanjay Kumar | |
| | William E. Grizzle | |
| | Jonathan A. Hensel | |
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| | The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes | Q24336630 |
| | LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells | Q24675869 |
| | Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3 | Q28117302 |
| | Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse | Q28237991 |
| | LL-37, the only human member of the cathelicidin family of antimicrobial peptides | Q28241675 |
| | The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection | Q28244066 |
| | The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1 | Q28574818 |
| | Cancer statistics, 2009 | Q29547625 |
| | Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. | Q30490685 |
| | Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils | Q33695688 |
| | An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. | Q34534186 |
| | Cathelicidins, essential gene-encoded mammalian antibiotics | Q34844987 |
| | A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. | Q36757262 |
| | Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer | Q37205544 |
| | VEGF inhibitors and prostate cancer therapy | Q37264085 |
| | Current perspectives on the Gleason grading of prostate cancer | Q37626796 |
| | In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. | Q38298534 |
| | Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2. | Q39970055 |
| | Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion | Q40062395 |
| | The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells | Q40086400 |
| | Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure | Q40407531 |
| | Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. | Q40425524 |
| | Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain | Q40432691 |
| | Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. | Q40479004 |
| | The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes | Q40581590 |
| | Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells | Q40584062 |
| | The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. | Q40590049 |
| | Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. | Q42815729 |
| | The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes | Q46314643 |
| | Processing site and gene structure for the murine antimicrobial peptide CRAMP. | Q46836549 |
| | Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. | Q50677677 |
| | CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma | Q52829169 |
| | Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy. | Q53668672 |
| | The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium | Q73043045 |
| | Akt takes center stage in angiogenesis signaling | Q73333632 |
| | Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation | Q73441800 |
| | The TRAMP mouse as a model for prostate cancer | Q81141767 |
| | Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37 | Q81245806 |
| | Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors | Q82928884 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 659-670 | |
| P577 | publication date | 2010-10-18 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | LL-37 as a therapeutic target for late stage prostate cancer | |
| | LL‐37 as a therapeutic target for late stage prostate cancer | |
| P478 | volume | 71 | |